Design and analysis of intra-subject variability in cross-over experiments

Statistics in Medicine

Volumn 15, Issue 15, 1996, Pages 1619-1634

  Chinchilli, Vernon M ^a   Esinhart, James D ^b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CROSSOVER PROCEDURE; DATA ANALYSIS; METHODOLOGY; STATISTICAL MODEL; VARIANCE;

AREA UNDER CURVE; BRONCHODILATOR AGENTS; CLINICAL TRIALS; CROSS-OVER STUDIES; ETHANOLAMINES; FORCED EXPIRATORY VOLUME; GASTROESOPHAGEAL REFLUX; HUMANS; LIKELIHOOD FUNCTIONS; MALE; METOCLOPRAMIDE; MODELS, STATISTICAL; RANDOMIZED CONTROLLED TRIALS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; THERAPEUTIC EQUIVALENCY; VERAPAMIL;

EID: 0029744834     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0258(19960815)15:15<1619::AID-SIM326>3.0.CO;2-N     Document Type: Article

References (21)

1. Bristol, D. R. 'Testing equality of treatment variances in a two-by-two crossover study', Journal of Biopharmaceutical Statistics, 1, 185-192 (1991).
2. Bristol, D. R. 'A confidence interval for the ratio of treatment variances in a two-by-two crossover study', Journal of Biopharmaceutical Statistics, 1, 237-245 (1991).
3. Liu, J. P. 'Bioequivalence and intrasubject variability', Journal of Biopharmaceutical Statistics, 1, 205-219 (1991).
4. Esinhart, J. D. and Chinchilli, V. M. 'Extension to the use of tolerance intervals for the assessment of individual bioequivalence', Journal of Biopharmaceutical Statistics, 4, 39-52 (1994).
5. Elswick, R. K., Jr. and Uthoff, V. A. 'A nonparametric approach to the analysis of the two-treatment, two-period, four-sequence crossover model', Biometrics, 45, 663-667 (1989).
6. Senn, S. Cross-over Trials in Clinical Research, Wiley, Chichester, England, 1993.
7. Laska, E. M., Meisner, M. and Kushner, H. B. 'Optimal crossover designs in the presence of carryover effects', Biometrics, 39, 1087-1091 (1983).
8. Williams, E. J. 'Experimental designs balanced for the residual effects of treatments', Australian Journal of Scientific Research, 2, 149-168 (1949).
9. 2 experimental units', Biometrics, 24, 61-73 (1968).
10. Ratkowsky, D. A., Evans, M. A. and Alldredge, J. R. Cross-over Experiments, Marcel Dekker, New York, 1993.
11. Grizzle, J. E. 'The two-period change over design and its use in clinical trials', Biometrics, 21, 467-480 (1965).
12. Jones, B. and Kenward, M. G. Design and Analysis of Cross-over Trials, Chapman and Hall, London, 1989.
13. Ekbohm, G. and Melander, H. 'The subject-by-formulation interaction as a criterion of interchangeability of drugs', Biometrics, 45, 1249-1254 (1989).
14. Sheiner, L. B. 'Bioequivalence revisited', Statistics in Medicine, 11, 1777-1788 (1992).
15. Chinchilli, V. M., Esinhart, J. D. and Barr, W. H. 'Analysis of multiple dose bioequivalence studies', Journal of Biopharmaceutical Statistics, 4, 423-435 (1994).
16. Laird, N. M. and Ware, J. H. 'Random effects models for longitudinal data', Biometrics, 38, 963-974 (1982).
17. Ware, J. H. 'Linear models for the analysis of longitudinal studies', American Statistician, 39, 95-101 (1985).
18. Jennrich, R. I. and Schluchter, M. D. 'Unbalanced repeated measures models with structural covariance matrices', Biometrics, 42, 805-820 (1986).
19. Anderson, T. W. An Introduction to Multivariate Statistical Analysis, 2nd edn, Wiley, New York, 1984.
20. Brown, M. B. and Forsythe, A. B. 'Robust tests for the equality of variances', Journal of the American Statistical Association, 69, 364-367 (1974).
21. Westlake, W. J. 'Bioavailability and bioequivalence of pharmaceutical formulations', in Peace (ed), Biopharmaceutical Statistics for Drug Development, Marcel Dekker, New York, 1988, pp. 329-352.